Cargando…

Nano-particle engineered atorvastatin delivery to support mesenchymal stem cell survival in infarcted myocardium

Atorvastatin (ATV) may support mesenchymal stem cells (MSC) survival in post-infarct myocardium (MI) as inflammatory reactions, oxidative stress and hypoxia condition get started in such tissues after damage. However, limited aqueous insolubility and rapid first-pass metabolism reduce the systemic a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yao, Guang-tao, Song, Li-ping, Xue, Wan-hua, Su, Guo-hai, Ning, Ai-hua, Wang, Jin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6117435/ https://www.ncbi.nlm.nih.gov/pubmed/30174496 http://dx.doi.org/10.1016/j.sjbs.2017.03.015

Ejemplares similares

Rapamycin-Preactivated Autophagy Enhances Survival and Differentiation of Mesenchymal Stem Cells After Transplantation into Infarcted Myocardium
por: Li, Zhi-hua, et al.
Publicado: (2020)

Naproxen and Diclofenac Attenuate Atorvastatin-induced Preconditioning of the Myocardium
por: Varga, Zoltan, et al.
Publicado: (2017)

Engineering Immunomodulatory Biomaterials for Regenerating the Infarcted Myocardium
por: Bloise, Nora, et al.
Publicado: (2020)

Mesenchymal stem cell‐loaded cardiac patch promotes epicardial activation and repair of the infarcted myocardium
por: Wang, Qiang‐li, et al.
Publicado: (2017)

Recent Advances in Cardiac Tissue Engineering for the Management of Myocardium Infarction
por: Sharma, Vineeta, et al.
Publicado: (2021)

Engineering the Cellular Microenvironment of Post-infarct Myocardium on a Chip
por: Khalil, Natalie N., et al.
Publicado: (2021)

Metformin induces apoptosis in mesenchymal stromal cells and dampens their therapeutic efficacy in infarcted myocardium
por: He, Xiao, et al.
Publicado: (2018)

Enhanced Electrical Integration of Engineered Human Myocardium via Intramyocardial versus Epicardial Delivery in Infarcted Rat Hearts
por: Gerbin, Kaytlyn A., et al.
Publicado: (2015)

Improving the efficacy of therapeutic angiogenesis by UTMD-mediated Ang-1 gene delivery to the infarcted myocardium
por: DENG, QING, et al.
Publicado: (2015)

Atorvastatin Enhance Efficacy of Mesenchymal Stem Cells Treatment for Swine Myocardial Infarction via Activation of Nitric Oxide Synthase
por: Song, Lei, et al.
Publicado: (2013)

Atorvastatin Attenuates Metabolic Remodeling in Ischemic Myocardium through the Downregulation of UCP2 Expression
por: Yang, Chunyan, et al.
Publicado: (2018)

In vitro preparation of infarcted myocardium.
por: Sasyniuk, B I
Publicado: (1978)

Engineered Exosomes With Ischemic Myocardium‐Targeting Peptide for Targeted Therapy in Myocardial Infarction
por: Wang, Xu, et al.
Publicado: (2018)

c-kit(+)VEGFR-2(+) Mesenchymal Stem Cells Differentiate into Cardiovascular Cells and Repair Infarcted Myocardium after Transplantation
por: Zhou, Pei, et al.
Publicado: (2022)

Mesenchymal stem cells conditioned with glucose depletion augments their ability to repair-infarcted myocardium
por: Choudhery, Mahmood S, et al.
Publicado: (2012)

Massive Calcification in the Myocardium Post Infarction
por: Joshi, Prathamesh V., et al.
Publicado: (2012)

Intramyocardial delivery of bFGF with a biodegradable and thermosensitive hydrogel improves angiogenesis and cardio-protection in infarcted myocardium
por: Zhu, Hongling, et al.
Publicado: (2017)

iPSC-derived human mesenchymal stem cells improve myocardial strain of infarcted myocardium
por: Miao, Qingfeng, et al.
Publicado: (2014)

Transplantation of genetically engineered cardiac fibroblasts producing recombinant human erythropoietin to repair the infarcted myocardium
por: Ruvinov, Emil, et al.
Publicado: (2008)

Bone marrow mesenchymal stem cells protected post-infarcted myocardium against arrhythmias via reversing potassium channels remodelling
por: Cai, Benzhi, et al.
Publicado: (2014)

Dose-dependent effects of atorvastatin on myocardial infarction
por: Barbarash, Olga, et al.
Publicado: (2015)

Thymosin β4 promotes the survival and angiogenesis of transplanted endothelial progenitor cells in the infarcted myocardium
por: Quan, Zhe, et al.
Publicado: (2017)

Magnetic resonance hypointensive signal primarily originates from extracellular iron particles in the long-term tracking of mesenchymal stem cells transplanted in the infarcted myocardium
por: Huang, Zheyong, et al.
Publicado: (2015)

Non-infarcted myocardium bears the weight in CVD
por: Zhou, Hui, et al.
Publicado: (2019)

Engraftment of engineered ES cell–derived cardiomyocytes but not BM cells restores contractile function to the infarcted myocardium
por: Kolossov, Eugen, et al.
Publicado: (2006)

ROS-responsive nano-drug delivery system combining mitochondria-targeting ceria nanoparticles with atorvastatin for acute kidney injury
por: Yu, Hui, et al.
Publicado: (2020)

Sodium ozagrel and atorvastatin for type 2 diabetes patients with lacunar cerebral infarction
por: Yu, You, et al.
Publicado: (2021)

Nano-engineered skin mesenchymal stem cells: potential vehicles for tumour-targeted quantum-dot delivery
por: Saulite, Liga, et al.
Publicado: (2017)

Pharmacokinetic—Pharmacodynamic Modeling of Tumor Targeted Drug Delivery Using Nano-Engineered Mesenchymal Stem Cells
por: Cheng, Shen, et al.
Publicado: (2021)

Strengthening effects of bone marrow mononuclear cells with intensive atorvastatin in acute myocardial infarction
por: Yang, Yue-Jin, et al.
Publicado: (2020)

Chemokine Contribution in Stem Cell Engraftment into the Infarcted Myocardium
por: Liehn, Elisa A, et al.
Publicado: (2013)

Modulators of Macrophage Polarization Influence Healing of the Infarcted Myocardium
por: ter Horst, Ellis N., et al.
Publicado: (2015)

The Role of Macrophages in the Infarcted Myocardium: Orchestrators of ECM Remodeling
por: O'Rourke, Sinead A., et al.
Publicado: (2019)

Intramyocardial hemorrhage drives fatty degeneration of infarcted myocardium
por: Cokic, Ivan, et al.
Publicado: (2022)

PCM and TAT co-modified liposome with improved myocardium delivery: in vitro and in vivo evaluations
por: Wang, Xin, et al.
Publicado: (2017)

Over-expression of HO-1 on mesenchymal stem cells promotes angiogenesis and improves myocardial function in infarcted myocardium
por: Zeng, Bin, et al.
Publicado: (2010)

PRDX2 in Myocyte Hypertrophy and Survival is Mediated by TLR4 in Acute Infarcted Myocardium
por: Jin, Xian, et al.
Publicado: (2017)

Atorvastatin treatment improves effects of implanted mesenchymal stem cells: meta-analysis of animal models with acute myocardial infarction
por: Dai, Guo, et al.
Publicado: (2015)

Optimization of Timing and Times for Administration of Atorvastatin‐Pretreated Mesenchymal Stem Cells in a Preclinical Model of Acute Myocardial Infarction
por: Xu, Jun, et al.
Publicado: (2019)

Simultaneous impact of atorvastatin and mesenchymal stem cells for glioblastoma multiform suppression in rat glioblastoma multiform model
por: Goodarzi, Arash, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7i71dmb79p433fjguh7c1p3gnr